BSE Live
Dec 13, 16:00Prev. Close
2.10
Open Price
1.90
Bid Price (Qty.)
2.10 (4839)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Nutraplus India (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -6.21 | 5.33 | 4.43 | 5.87 | 4.49 | |
| Diluted EPS (Rs.) | -6.21 | 5.33 | 4.20 | 5.87 | 4.33 | |
| Cash EPS (Rs.) | -2.38 | 8.05 | 6.66 | 6.93 | 5.49 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 42.26 | 34.35 | 30.06 | 24.66 | 20.02 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 42.26 | 34.35 | 30.06 | 24.66 | 20.02 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 58.26 | 104.65 | 70.63 | 86.07 | 76.19 | |
| PBDIT/Share (Rs.) | 3.05 | 17.46 | 13.41 | 12.42 | 10.71 | |
| PBIT/Share (Rs.) | 1.79 | 14.72 | 11.09 | 11.21 | 9.52 | |
| PBT/Share (Rs.) | -2.25 | 8.67 | 6.80 | 8.22 | 6.98 | |
| Net Profit/Share (Rs.) | -3.64 | 5.31 | 4.34 | 5.72 | 4.30 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 5.22 | 16.68 | 18.98 | 14.42 | 14.05 | |
| PBIT Margin (%) | 3.07 | 14.06 | 15.69 | 13.01 | 12.49 | |
| PBT Margin (%) | -3.86 | 8.27 | 9.62 | 9.54 | 9.15 | |
| Net Profit Margin (%) | -6.24 | 5.07 | 6.14 | 6.64 | 5.64 | |
| Return on Networth / Equity (%) | -8.60 | 15.46 | 14.44 | 23.20 | 21.47 | |
| Return on Capital Employed (%) | -6.30 | 8.22 | 8.51 | 14.05 | 13.61 | |
| Return on Assets (%) | -3.55 | 4.16 | 4.46 | 6.81 | 7.13 | |
| Total Debt/Equity (X) | 0.76 | 1.42 | 1.12 | 1.01 | 0.92 | |
| Asset Turnover Ratio (%) | 57.02 | 81.99 | 72.59 | 102.59 | 126.39 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.53 | 1.03 | 1.01 | 1.00 | 1.19 | |
| Quick Ratio (X) | 1.18 | 0.51 | 0.58 | 0.70 | 0.89 | |
| Inventory Turnover Ratio (X) | 3.74 | 3.20 | 3.62 | 6.56 | 8.88 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 100.00 | 100.00 | 100.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 100.00 | 100.00 | 100.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 152.10 | 35.12 | 24.55 | 21.67 | 13.63 | |
| EV/Net Operating Revenue (X) | 2.34 | 0.57 | 0.62 | 0.48 | 0.38 | |
| EV/EBITDA (X) | 44.72 | 3.41 | 3.27 | 3.36 | 2.68 | |
| MarketCap/Net Operating Revenue (X) | 1.97 | 0.13 | 0.18 | 0.22 | 0.17 | |
| Retention Ratios (%) | 0.00 | 0.00 | 100.00 | 100.00 | 100.00 | |
| Price/BV (X) | 2.71 | 0.38 | 0.43 | 0.78 | 0.65 | |
| Price/Net Operating Revenue | 1.97 | 0.13 | 0.18 | 0.22 | 0.17 | |
| Earnings Yield | -0.03 | 0.40 | 0.34 | 0.30 | 0.33 |
29.05.2019
Nutraplus India Standalone March 2019 Net Sales at Rs 35.80 crore, up 2.2% Y-o-Y
18.02.2019
Nutraplus India Standalone December 2018 Net Sales at Rs 42.94 crore, up 37.89% Y-o-Y
15.11.2018
Nutraplus India Standalone September 2018 Net Sales at Rs 32.09 crore, up 30.95% Y-o-Y
07.02.2017
Stocks in news: Idea, Bharti Infra, Titagarh, Honeywell, Caplin
29.05.2019
Nutraplus India Standalone March 2019 Net Sales at Rs 35.80 crore, up 2.2% Y-o-Y
18.02.2019
Nutraplus India Standalone December 2018 Net Sales at Rs 42.94 crore, up 37.89% Y-o-Y
15.11.2018
Nutraplus India Standalone September 2018 Net Sales at Rs 32.09 crore, up 30.95% Y-o-Y
17.08.2015
Nutraplus India consolidated Jun '15 sales at Rs 15.28 crore
09.04.2026
08.04.2026
Indian CDMOs face tariff exposure via patented drug supply chains
08.04.2026
08.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth